Bristol-Myers Squibb's quarterly net rises 16%

Posted on April 29, 2010 at 08:15 AM EDT

Bristol-Myers Squibb generates 16% growth in first-quarter earnings, aided by rising sales of it most popular drug, as the drugmaker updates its 2010 profit outlook to reflect the impact of U.S. health-care reform.

Related Stocks:

Bristol-Myers Squibb Co. Mead Johnson Nutrition Co.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates